Home Cart 0 Sign in  
X

[ CAS No. 24410-59-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 24410-59-1
Chemical Structure| 24410-59-1
Chemical Structure| 24410-59-1
Structure of 24410-59-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 24410-59-1 ]

Related Doc. of [ 24410-59-1 ]

Alternatived Products of [ 24410-59-1 ]

Product Details of [ 24410-59-1 ]

CAS No. :24410-59-1 MDL No. :MFCD08236757
Formula : C8H5FO Boiling Point : -
Linear Structure Formula :- InChI Key :FTVHMXRCGNWCOL-UHFFFAOYSA-N
M.W : 136.12 Pubchem ID :11788322
Synonyms :

Calculated chemistry of [ 24410-59-1 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 36.17
TPSA : 13.14 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.02
Log Po/w (XLOGP3) : 2.43
Log Po/w (WLOGP) : 2.99
Log Po/w (MLOGP) : 2.0
Log Po/w (SILICOS-IT) : 2.87
Consensus Log Po/w : 2.46

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.88
Solubility : 0.179 mg/ml ; 0.00132 mol/l
Class : Soluble
Log S (Ali) : -2.35
Solubility : 0.61 mg/ml ; 0.00448 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.53
Solubility : 0.0398 mg/ml ; 0.000292 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.22

Safety of [ 24410-59-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 24410-59-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 24410-59-1 ]
  • Downstream synthetic route of [ 24410-59-1 ]

[ 24410-59-1 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 59769-37-8 ]
  • [ 24410-59-1 ]
YieldReaction ConditionsOperation in experiment
67% for 1.5 h; Reflux General procedure: A 25 mL round-bottomed flask was charged with 2-aryloxyacetaldehyde diethyl acetals (1 mmol), Sn-b (0.1 g), andtrifluorotoluene (10 mL). The mixture was stirred under refluxingcondition and monitored by GC. Upon completion, the mixture wascooled to room temperature, and the catalyst Sn-b was filtrate off.The filter cake was washed with trifluorotoluene (10 mL3). Thecombined filtratewas concentrated under vacuum. The residuewaspurified by flash column chromatography on SiO2 (petroleumether/ethyl acetate) to afford the desired 2,3-unsubstituted benzo[b]furans.
45% With PPA In benzene for 2.5 h; Heating / reflux To a mixture of benzene (200 ml) containing polyphosphoric acid (7.9 g, 0.035 mol) was added 2-(4-fluoro-phenoxy)-acetaldehyde diethyl acetal (8 g, 0.035 mol). The mixture was stirred vigorously while being heated to reflux for 2.5 hours. The reaction mixture was cooled to room temperature and decanted from the polyphosphoric acid. The solvent was removed under vacuum. Chromatography (5percent ethyl acetate-hexanes) afforded 3.4 g (45percent) of product as a clear oil: 1H NMR (CDCl3) δ 6.74 (dd, 1H, J = 2.0, 0.6 Hz), 7.01 (td, 1H, J = 9, 2.7 Hz), 7.25 (dd, 1H, J = 8.4, 2.7 Hz), 7.43 ( dd, 1H, J = 9, 3.9 Hz), 7.65 (d, 1H, J = 1.8 Hz).
Reference: [1] Tetrahedron, 2015, vol. 71, # 29, p. 4835 - 4841
[2] Journal of Medicinal Chemistry, 2004, vol. 47, # 15, p. 3823 - 3842
[3] Patent: EP1147083, 2004, B1, . Location in patent: Page 35
[4] Journal of the American Chemical Society, 2017, vol. 139, # 24, p. 8267 - 8276
[5] European Journal of Organic Chemistry, 2016, vol. 2016, # 13, p. 2268 - 2273
[6] Journal of Medicinal Chemistry, 2004, vol. 47, # 7, p. 1609 - 1612
[7] Patent: EP1380576, 2004, A1, . Location in patent: Page 66
[8] Patent: WO2011/99010, 2011, A1, . Location in patent: Page/Page column 38
[9] Patent: US2012/225863, 2012, A1, . Location in patent: Page/Page column 17
[10] Patent: WO2012/119046, 2012, A2, . Location in patent: Page/Page column 65-66
[11] New Journal of Chemistry, 2016, vol. 40, # 8, p. 6564 - 6567
  • 2
  • [ 371-41-5 ]
  • [ 24410-59-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 15, p. 3823 - 3842
[2] Journal of Medicinal Chemistry, 2004, vol. 47, # 7, p. 1609 - 1612
[3] Patent: US2012/225863, 2012, A1,
[4] Patent: WO2012/119046, 2012, A2,
[5] Patent: WO2015/42397, 2015, A1,
[6] Tetrahedron, 2015, vol. 71, # 29, p. 4835 - 4841
[7] European Journal of Organic Chemistry, 2016, vol. 2016, # 13, p. 2268 - 2273
[8] New Journal of Chemistry, 2016, vol. 40, # 8, p. 6564 - 6567
[9] Journal of the American Chemical Society, 2017, vol. 139, # 24, p. 8267 - 8276
  • 3
  • [ 24410-59-1 ]
  • [ 5419-55-6 ]
  • [ 473416-33-0 ]
YieldReaction ConditionsOperation in experiment
26%
Stage #1: With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran; hexane at -60 - -10℃; for 75 h; Inert atmosphere
Stage #2: at -60 - 20℃; Inert atmosphere
Stage #3: With hydrogenchloride; water In tetrahydrofuran; hexane
Step 3. 5-Fluorobenzofuran-2-ylboronic acid To a solution of 5-fluorobenzofuran (10 g, 73.53 mmol) in dry tetrahydrofuran (250 mL) was added tetramethylethylenediamine (10.2 g, 87.93 mmol). The solution was kept below -60° C. under nitrogen, while BuLi (93.75 mmol, 2.5M solution in hexane) was added dropwise. It was warmed to -10° C. during 45 min and stirred at this temperature for another 30 min. The mixture was cooled again below -60° C. followed by dropwise addition of triisopropyl borate (41.4 g, 220.21 mmol). After warming to room temperature the mixture was quenched with hydrochloric acid (70 mL, 2N) and stirred for 1 h. The alkaline aqueous layer was brought to pH 5 and extracted with ethyl acetate (3.x.80 mL). All organic layers were combined, dried over sodium sulfate, and concentrated in vacuo to give 5-fluorobenzofuran-2-ylboronic acid (3.5 g, 26percent) which was used for the next step without further purification.1H-NMR (300 MHz, CDCl3): δ 8.63 (s, 2H), 7.58-7.62 (m, 1H), 7.44-7.49 (m, 2H), 7.15-7.22 (m, 1H)
Reference: [1] Patent: US2012/225863, 2012, A1, . Location in patent: Page/Page column 17-18
  • 4
  • [ 24410-59-1 ]
  • [ 150-46-9 ]
  • [ 473416-33-0 ]
Reference: [1] Patent: EP1380576, 2004, A1, . Location in patent: Page 67
  • 5
  • [ 24410-59-1 ]
  • [ 5419-55-6 ]
  • [ 7732-18-5 ]
  • [ 473416-33-0 ]
Reference: [1] Patent: WO2012/119046, 2012, A2, . Location in patent: Page/Page column 66
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 24410-59-1 ]

Fluorinated Building Blocks

Chemical Structure| 24410-58-0

[ 24410-58-0 ]

4-Fluorobenzofuran

Similarity: 0.97

Chemical Structure| 24410-61-5

[ 24410-61-5 ]

7-Fluorobenzofuran

Similarity: 0.88

Chemical Structure| 246029-02-7

[ 246029-02-7 ]

5-Fluorobenzofuran-7-ol

Similarity: 0.76

Chemical Structure| 33118-83-1

[ 33118-83-1 ]

5-Fluoro-3-methylbenzofuran

Similarity: 0.74

Chemical Structure| 286836-04-2

[ 286836-04-2 ]

5-Bromo-7-fluorobenzofuran

Similarity: 0.71

Related Parent Nucleus of
[ 24410-59-1 ]

Benzofurans

Chemical Structure| 24410-58-0

[ 24410-58-0 ]

4-Fluorobenzofuran

Similarity: 0.97

Chemical Structure| 24410-61-5

[ 24410-61-5 ]

7-Fluorobenzofuran

Similarity: 0.88

Chemical Structure| 246029-02-7

[ 246029-02-7 ]

5-Fluorobenzofuran-7-ol

Similarity: 0.76

Chemical Structure| 271-89-6

[ 271-89-6 ]

Benzofuran

Similarity: 0.76

Chemical Structure| 33118-83-1

[ 33118-83-1 ]

5-Fluoro-3-methylbenzofuran

Similarity: 0.74